Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Name: Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
License: Public Domain

AstraZeneca

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

urinary bladder neoplasms, immune checkpoint inhibitors, methotrexate, vinblastine, doxorubicin, cisplatin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444883
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.